Abstract

Background/Objectives

The progression of carotid-plaque volume in patients with type 2 diabetes is common. Previous observational studies showed an association between moderate alcohol and reduced risk of coronary disease. We examined whether consuming moderate wine affects the progression of carotid atherosclerosis.

Subjects/Methods

In the CASCADE (CArdiovaSCulAr Diabetes and Ethanol), a 2-year randomized controlled trial, we randomized abstainers with type 2 diabetes were to drink 150 ml of either red wine, white wine, or water, provided for 2 years. In addition, groups were guided to maintain a Mediterranean diet. We followed 2-year changes in carotid total plaque volume (carotid-TPV) and carotid vessel wall volume (carotid-VWV), using three-dimensional ultrasound.

Results

Carotid images were available from 174 of the 224 CASCADE participants (67% men; age = 59 yr; HbA1C = 6.8%). Forty-five percent had detectable plaque at baseline. After 2 years, no significant progression in carotid-TPV was observed (water, −1.4 (17.0) mm3, CI (−2.7, 5.5), white-wine, −1.2 (16.9) mm3, CI (−3.8, 6.2), red wine, −1.3 (17.6) mm3, CI (−3.4, 6.0; p = 0.9 between groups)). In post hoc analysis, we divided the 78 participants with detectable baseline carotid plaque into tertiles. Those with the higher baseline plaque burden, whom were assigned to drink wine, reduced their plaque volume significantly after 2 years, as compared to baseline.

Two-year reductions in Apo(B)/Apo(A) ratio(s) were independently associated with regression in carotid-TPV (β = 0.4; p < 0.001). Two-year decreases in systolic blood pressure were independently associated with regression in carotid-VWV (β = 0.2; p = 0.005).

Conclusions

No progression in carotid-TPV was observed. In subgroup analyses, those with the greatest plaque burden assigned to drink wine may have had a small regression of plaque burden

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and hemostatic factors. Br Med J. 1999;319:1523–8.

  2. 2.

    Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267–73.

  3. 3.

    Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients. Diabetologia. 2006;49:648–52.

  4. 4.

    Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm EB, et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation. 2000;102:494–9.

  5. 5.

    Juonala M, Viikari JS, Kähönen M, Laitinen T, Taittonen L, Loo BM, et al. Alcohol consumption is directly associated with carotid intima–media thickness in Finnish young adults: The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2009;204:e93–8.

  6. 6.

    Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2010;55:1339–47.

  7. 7.

    Liu W, Redmond EM, Morrow D, Cullen JP. Differential effects of daily-moderate versus weekend-binge alcohol consumption on atherosclerotic plaque development in mice. Atherosclerosis. 2011;219:448–54. https://doi.org/10.1016/j.atherosclerosis.2011.08.034

  8. 8.

    Kohsaka S, Jin Z, Rundek T, Homma S, Sacco RL, Di Tullio MR. Alcohol consumption and atherosclerotic burden in the proximal thoracic aorta. Atherosclerosis. 2011;219:794–8.

  9. 9.

    Mallett C, House AA, Spence JD, Fenster A, Parraga G. Longitudinal ultrasound evaluation of carotid atherosclerosis in one, two and three dimensions. Ultrasound Med Biol. 2009;35:367–75.

  10. 10.

    Wagenknecht LE, Zaccaro D, Espeland MA, Karter AJ, O’Leary DH, Haffner SM. Diabetes and progression of carotid atherosclerosis the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 2003;23:1035–4.

  11. 11.

    Makris GC, Lavida A, Griffin M, Geroulakos G, Nicolaides AN. Three-dimensional ultrasound imaging for the evaluation of carotid atherosclerosis. Atherosclerosis. 2011;219:377–83.

  12. 12.

    Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis. 2012;220:128–33.

  13. 13.

    Wannarong T, Parraga G, Buchanan D, Fenster A, House AA, Hackam DG, et al. Progression of carotid plaque volume predicts cardiovascular events. Stroke. 2013;44:1859–65.

  14. 14.

    Spence JD, Parraga G. Three-dimensional ultrasound of carotid plaque. Neuroimaging Clin N Am. 2016;26:69–80. https://doi.org/10.1016/j.nic.2015.09.006

  15. 15.

    Shai I, Spence JD, Schwarzfuchs D, Henkin Y, Parraga G, Rudich A, Fenster A, et al. Dietary intervention to reverse carotid atherosclerosis. Circulation. 2010;121:1200–8.

  16. 16.

    Chiu B, Egger M, Spence JD, Parraga G, Fenster A. Quantification of carotid vessel wall and plaque thickness change using 3D ultrasound images. Med Phys. 2008;35:3691–710.

  17. 17.

    Shai I, Wainstein J, Harman-Boehm I, Raz I, Fraser D, Rudich A, et al. Glycemic effects of moderate alcohol intake among patients with type 2 diabetes. Diabetes Care. 2007;30:3011–6.

  18. 18.

    Gepner Y, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Shelef I, et al. Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes a 2-year randomized, controlled trial. Ann Intern Med. 2015;163:569–79.

  19. 19.

    Shai I, Rosner BA, Shahar DR, Vardi H, Azrad AB, Kanfi A, et al. Dietary evaluation and attenuation of relative risk: multiple comparisons between blood and urinary biomarkers, food frequency, and 24-hour recall questionnaires: the DEARR study. J Nutr. 2005;135:573–9.

  20. 20.

    Golan R, Schwarzfuchs D, Stampfer MJ, Shai I. Halo effect of a weight-loss trial on spouses: the DIRECT-Spouse study. Public Health Nutr. 2010;13:544–9.

  21. 21.

    Egger M, Spence JD, Fenster A, Parraga G. Validation of 3D ultrasound vessel wall volume: an imaging phenotype of carotid atherosclerosis. Ultrasound Med Biol. 2007;33:905–14.

  22. 22.

    Krasinski A, Chiu B, Spence JD, Fenster A, Parraga G. Three dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis. Ultrasound Med Biol. 2009;35:1763–72.

  23. 23.

    Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke. 2005;36:1904–9.

  24. 24.

    Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, et al. Gender differences in pharmacokinetics of alcohol. Alcohol: Clin Exp Res. 2001;25:502–7.

  25. 25.

    Tatsumi Y, Morimoto A, Asayama K, Sonoda N, Miyamatsu N, Ohno Y, Miyamoto Y, Izawa S, Ohkubo T Association between alcohol consumption and incidence of impaired insulin secretion and insulin resistance in Japanese: the Saku study. Diabetes Res Clin Pract. 2017. pii: S0168-8227;31228-7. https://doi.org/10.1016/j.diabres.2017.10.021.

  26. 26.

    Kim JY, Lee DY, Lee YJ, Park KJ, Kim KH, Kim JW. et l. Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunction. World J Biol Chem. 2015;6:1–15. http://doi.org/10.4331/wjbc.v6.i1.1

  27. 27.

    OECD (2011), Health at a Glance 2011: OECD Indicators, OECD Publishing. https://doi.org/10.1787/health_glance-2011-en

  28. 28.

    Maiorino MI, Bellastella G, Petrizzo M, Gicchino M, Caputo M, Giugliano D, et al. Effect of a Mediterranean diet on endothelial progenitor cells and carotid intima-media thickness in type 2 diabetes: follow-up of a randomized trial. Eur J Prev Cardiol. 2017;24:399–408.

  29. 29.

    Gardener H, Wright CB, Cabral D, Scarmeas N, Gu Y, Cheung K, et al. Mediterranean diet and carotid atherosclerosis in the Northern Manhattan Study. Atherosclerosis. 2014;234:303–10.

  30. 30.

    Murie-Fernandez M, Irimia P, Toledo E, Martínez-Vila E, Buil-Cosiales P, Serrano-Martínez M, et al. Carotid intima-media thickness changes with Mediterranean diet: a randomized trial (PREDIMED-Navarra). Atherosclerosis. 2011;219:158–62.

  31. 31.

    Sala-Vila A, Romero-Mamani ES, Gilabert R, Núñez I, de la Torre R, Corella D, et al. Changes in ultrasound-assessed carotid intima-media thickness and plaque with a Mediterranean diet. Arterioscler Thromb Vasc Biol. 2014;34:439–45.

  32. 32.

    Zanchetti A, Crepaldi G, Bond MG, Gallus GV, Veglia F, Ventura A, et al. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima–media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. J Hypertens. 2001;19:79–88.

  33. 33.

    Su TC, Jeng JS, Chien KL, Sung FC, Hsu HC, Lee YT. Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke. 2001;32:2265–71.

  34. 34.

    Herder M, Johnsen SH, Arntzen KA, Mathiesen EB. Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study. Stroke. 2012;43:1818–23.

  35. 35.

    Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens. 2012;14:792–8.

  36. 36.

    Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083–93.

  37. 37.

    Chiva-Blanch G, Urpi-Sarda M, Ros E, Arranz S, Valderas-Martínez P, Casas R, et al. Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ Res. 2012;111:1065–1068v.

  38. 38.

    Gepner Y, Henkin Y, Schwarzfuchs D, Golan R, Durst R, Shelef I, et al. Differential effect of initiating moderate red wine consumption on 24-h blood pressure by alcohol dehydrogenase genotypes: randomized trial in type 2 diabetes. Am J Hypertens. 2016;29:476–83. https://doi.org/10.1093/ajh/hpv126

Download references

Acknowledgements

We acknowledge the participants of CASCADE for their valuable collaboration. We honor Harel Segal and Osnat Tangi-Rosental; we thank Dr. Tatiana Shuster, Sagit Saadon, Malka Kaminsky, Yasmin Asuly, Roman Tsirkin, David Shushan, Tamara Lipovetzky-Yasky, Maya Rovner, Ortal Chadad from Soroka-Medical-Center; Eyal Goshen, Meir Aviv, Hassia Krakauer, Haim Strasler, Dr. Ziva Schwartz, Dr. Einat Sheiner, Dr. Dov Brickner, Dr. Rachel Marko, Esther Katorza, Ilanit Asulin, Tzvika Tzur from Nuclear Research Center Negev; Canadian 3DUS team Aaron Fenster, Christiane Mallett, David Tessier, Andrew Wheatley, Christine Piechowicz, Sandra Halko, Shayna McKay, Shi Sherebrin, and Maria DiCiccco for their important contributions.

Funding

This study was funded by the European Foundation for the Study of Diabetes, which had no role in the design, analysis, or writing of this article.

Author information

Affiliations

  1. Ben-Gurion University of the Negev, Beer Sheva, Israel

    • Rachel Golan
    • , Iris Shai
    • , Yftach Gepner
    • , Michael Friger
    • , Sivan Ben-Avraham
    • , Dana Sefarty
    • , Nitzan Bril
    • , Michal Rein
    • , Noa Cohen
    •  & Assaf Rudich
  2. Soroka University Medical Center, Beer-Sheva, Israel

    • Ilana Harman-Boehm
    • , Shula Witkow
    • , Idit F Liberty
    •  & Yaakov Henkin
  3. Israel Nuclear Research Center Negev, Dimona, Israel

    • Dan Schwarzfuchs
    •  & Benjamin Sarusi
  4. Robarts Research Institute, University of Western Ontario, London, ON, Canada

    • J. David Spence
    • , Grace Parraga
    •  & Dan Buchanan
  5. Department of Medicine, University of Leipzig, Leipzig, Germany

    • Uta Ceglarek
    • , Joachim Thiery
    • , Michael Stumvoll
    •  & Matthias Blüher
  6. Department of Medicine, Channing Laboratory, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    • Meir J Stampfer
  7. Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA, USA

    • Meir J Stampfer

Authors

  1. Search for Rachel Golan in:

  2. Search for Iris Shai in:

  3. Search for Yftach Gepner in:

  4. Search for Ilana Harman-Boehm in:

  5. Search for Dan Schwarzfuchs in:

  6. Search for J. David Spence in:

  7. Search for Grace Parraga in:

  8. Search for Dan Buchanan in:

  9. Search for Shula Witkow in:

  10. Search for Michael Friger in:

  11. Search for Idit F Liberty in:

  12. Search for Benjamin Sarusi in:

  13. Search for Sivan Ben-Avraham in:

  14. Search for Dana Sefarty in:

  15. Search for Nitzan Bril in:

  16. Search for Michal Rein in:

  17. Search for Noa Cohen in:

  18. Search for Uta Ceglarek in:

  19. Search for Joachim Thiery in:

  20. Search for Michael Stumvoll in:

  21. Search for Matthias Blüher in:

  22. Search for Meir J Stampfer in:

  23. Search for Assaf Rudich in:

  24. Search for Yaakov Henkin in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Rachel Golan.

Electronic supplementary material

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/s41430-018-0091-4